Practical Derm

🎤🤵‍♂️C-SUITE CHAT: Cosmo Pharmaceuticals CEO Giovanni Di Napoli discusses the challenges posed by androgenetic alopecia (AGA) and the potential impact of a clascoterone 5% topical solution based on new Phase 3 data. Watch here ➡️ ow.ly/UrAf50YUqB6 #Pharmaceuticals #CosmoPharmaceuticals #AndrogeneticAlopecia #HairLossTreatment #Dermatology

🔎💇‍♀️HAIR LOSS FOCUS: Practical Dermatology Editorial Board member Amy Spizuoco, DO, FAOCD, FAAD, previews the upcoming meeting that she co-founded, the DermVIP Summit, which will focus hair loss and scalp conditions along with inflammatory skin diseases ➡️ ow.ly/KNC350YTSeJ #HairLoss #Dermatology #ScalpHealth #InflammatorySkin #DermVIPSummit #HairCare

👀 📊 NEW: A melanoma PRS improved prediction beyond clinical factors alone, raising MP16 discrimination from 0.713 to 0.729 in QSkin ➡️ ow.ly/IgXO50YT0p0 #Dermatology #Melanoma #PrecisionMedicine #SkinCancerAwareness

🎤👩‍⚕️ON SCENE: At the 67th Noah Worcester Dermatological Society Annual Meeting, Practical Dermatology Associate Medical Editor Lisa Swanson, MD, FAAD, delivered the Alfred L. Weiner Lecture titled “Afraid to Treat Kids? Here are some Pearls to Help!” focusing on practical, clinic-ready strategies to improve care for pediatric patients, emphasizing communication, therapeutic updates, and clinician confidence. Read more ➡️ ow.ly/RRuC50YRZcE #Dermatology #PediatricDermatology #SkinCare #PediatricCare

🚨NEW: Povorcitinib hits Phase 3 endpoints in vitiligo (P < .001), while HS and AD programs advance. Busy pipeline ahead for Incyte ➡️ ow.ly/Ls8250YRxnZ #dermatology #vitiligo #hidradenitissuppurativa #aesthetics #clinicaltrials

🧴📊 BPO SAFETY UPDATE: Meta-analysis of >4M patients shows no significant association with leukemia, AML, lymphoma, or hematologic malignancy ➡️ ow.ly/JpQ050YQPQn #dermatology #acne #patientsafety #BPO #cancerawareness #skincancer #mednews

🤖🔎🩺 AI AFFECTING PATIENT UNDERSTANDING: AI skin apps may boost patient diagnostic accuracy vs web search (22.8% vs 7.9%). But accuracy depends on quality of predictions. JAMA Dermatology study highlights both promise and gaps. #Dermatology #AI #DigitalHealth ➡️ ow.ly/4qG350YQ0nc #Dermatology #DigitalHealth #AIinMedicine #SkinHealth #HealthTech

🩺📊ON DEFINING REMISSION IN AD: Global experts recently defined what “remission” really means in eczema care, in a move toward standardizing outcomes for better trials and treatment goals ➡️ ow.ly/Vhv150YQ0ll #eczema #atopicdermatitis #dermatology #skincaretech #AtopicDermatitis #DermTwitter

🚨ALERT: FDA finds 6 more gel nail removers with banned methylene chloride. Labeling inconsistencies raise safety concerns. Read which products are affected ➡️ ow.ly/XVhr50YPjVY #DermNews #FDA #Cosmetics

📢NEW: Ultrasound & CT bested physical exam for nodal staging in high-risk #cSCC—but sensitivity dropped sharply in immunosuppressed patients ➡️ ow.ly/g7hM50YOQf6 #Dermatology #SkinCancer #Imagine #ComputedTomography #cSCC

📢 👀 APRIL ISSUE NOW LIVE: The April 2026 issue of Practical Dermatology is now live - delve into a focused, expert-driven examination of issues surrounding acne and rosacea 👉 ow.ly/AJfs50YOjZS #dermatology #acne #rosacea #skin #skinhealth

🛑 CKD COMPLICATES POST-MOHS RECOVERY: Chronic kidney disease (CKD) was associated with increased postoperative complications following Mohs micrographic surgery (MMS) ➡️ ow.ly/JANV50YN964 #ChronicKidneyDisease #CKD #MohsSurgery #DermatologyResearch

🔎📊 PDT VS. CRYO FOR ACTINIC KERATOSIS: A recent systematic review and meta-analysis suggested comparable efficacy and safety of photodynamic therapy (PDT) and cryotherapy for lesion clearence in actinic keratosis ➡️ ow.ly/1r5r50YMhTC #Dermatology #ActinicKeratosis

👀🧴🩺 What’s Next for Pediatric AD: Larry Eichenfield, MD, talks about the recent INTEGUMENT-OLE data and the impact of the roflumilast cream 0.05% (Zoryve) on the treatment of mild-to-moderate AD in children aged 2 to 5 years ➡️ ow.ly/2kTj50YMgzm

DEFINITIONS MATTER: The International Eczema Council (IEC) defines LDA, vLDA, and remission in AD—bringing much-needed standardization to trials and practice ➡️ ow.ly/evFS50YLpyl #Eczema #Dermatology #SkinHealth #AtopicDermatitis #EczemaAwareness #DermTwitter

👀🆕 NEW: A study in JAMA Dermatology explores how AI-powered dermatology tools influence patient understanding of skin conditions ➡️ ow.ly/SioT50YKL1Z #Dermatology #DigitalHealth #AIinMedicine

NEW: A recent pharmacovigilance study using the FDA Adverse Event Reporting System (FAERS) database found no significant association between topical calcineurin inhibitors (TCIs) and lymphoma, despite longstanding boxed warnings in the United States ➡️ ow.ly/3uyl50YJ5lq

👀🔬Pushing the Envelope in PN Research: Integrative Dermatologist Raja Sivamani, MD, MS, AP, discusses different aspects of prurigo nodularis ➡️ ow.ly/qnrF50YItMw #PrurigoNodularis #IntegrativeDermatology #SkinHealth #ClinicalDermatology #PatientCare

💊 🩺 MATCHING THE RIGHT TREATMENT TO THE RIGHT AD PATIENTS: Justin Marson, MD, of SUNY Downstate Health Science University, explains how to select the optimal therapeutic option for each different atopic dermatitis patient➡️ ow.ly/2NVz50YGsEN #AtopicDermatitis #Dermatology #SkinCare #MedicalEducation #PatientCare #SkinHealth

🔎🔬SYSTEMIC STEROIDS IN ATOPIC DERMATITIS: Practical Dermatology Editorial Board member Todd Schlesinger, MD, discusses the role of systemic steroids in treating atopic dermatitis ➡️ ow.ly/x20J50YGsgI #AtopicDermatitis #Dermatology #SkinHealth #SystemicSteroids #MohsSurgery #Dermatologist